Clinical Trial Update: Targeting LOXL2 and Cardiac Fibrosis for Post-acute Heart Failure Treatment- A Prospective Study

View source ↗

Summary

A prospective study evaluating LOXL2 targeting for post-acute heart failure with decompensation; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Heart Failure; With Decompensation | Status: RECRUITING